Journal of Clinical Pathology · 1997 · 33 citations · 11 references
MedicineGeneticsPathologyMolecular PathologyRenal PathologyRenal PathophysiologyGenetic SyndromesGlomerular DiseasesGlomerular PathophysiologyHereditary Renal DiseasesRenal DiseaseBasement Membrane DefectsGlomerular Basement Membrane AntigensKidney DiseasesType Iv Collagen
BACKGROUND: Epstein's syndrome is defined as a subtype of Alport's syndrome, and is distinguished from the other subtypes by accompanying macrothrombocytopenia. Mutations in collagen IV genes are known to be involved in the pathogenesis of typical Alport's syndrome. However, the presence of an underlying genetic defect has not been demonstrated in Epstein's syndrome. AIM: To clarify the involvement of collagen IV in Epstein's syndrome. METHODS: The distribution of the alpha(IV) chain was studied in renal specimens obtained from three patients with Epstein's syndrome using chain specific monoclonal antibodies and an antigen retrieval procedure. RESULTS: The patients showed a normal distribution of alpha(IV) chains: alpha 1(IV) and alpha 2(IV) were expressed ubiquitously, whereas expression of alpha 3(IV) through to alpha 6(IV) chains was limited to the glomerular basement membrane, Bowman's capsular basement membrane, and/or a portion of the tubular basement membrane. CONCLUSIONS: These results suggest that genes other than those encoding alpha(IV) chains are responsible for the pathogenesis of Epstein's syndrome.
11
Identification of Mutations in the COL4A5 Collagen Gene in Alport Syndrome
David F. Barker, Sirkka Liisa Hostikka, Jing Zhou et al. · Science · 1990 · 881 citations
Hereditary macrothrombocytopathia, nephritis and deafness
Charles J. Epstein, Mervyn A. Sahud, Carolyn F. Piel et al. · The American Journal of Medicine · 1972 · 247 citations
Medicine, Nephrology, Pathology +12
Yoshikazu Sado, Megumi Kagawa, Yumiko Kishiro et al. · Histochemistry and Cell Biology · 1995 · 206 citations